Abiopharma

Director Patni Rajiv 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002980

Galbraith Kenneth 🟡 adjusted position in 551.6K shares (4 derivative) of Zymeworks Inc. (ZYME) at $23.16 ($5.7M) Transaction Date: Jan 12, 2026 | Filing ID: 010790

Director MUELLER PETER 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002979

Director Votruba Michal 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002978

Director MILLER MICHAEL PATRICK 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002976

Director Bray June 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002975

Director MACK DAVID J. 🟢 acquired 17.0K shares (1 derivative) of BioXcel Therapeutics, Inc. (BTAI) at $2.01 Transaction Date: Jan 09, 2026 | Filing ID: 002973

Zuga Matt 🔴 sold 6.9K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.82 Transaction Date: Jan 08, 2026 | Filing ID: 001898

Barton Russell 🔴 sold 3.5K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.86 Transaction Date: Jan 08, 2026 | Filing ID: 001897

Meisner Derek M 🔴 sold 50.7K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.82 Transaction Date: Jan 08, 2026 | Filing ID: 001896